Table 2.
Site | |||||||
---|---|---|---|---|---|---|---|
Middle | Margins | ||||||
Factor | Time | Sorrento + BMA | Vitoss Foam Strip + BMA | Autograft | Sorrento + BMA | Vitoss Foam Strip + BMA | Autograft |
Cathepsin-K (CAT-K) | 3 weeks | +++ | ++ | + | + | ++ | + |
Alkaline phosphatase (ALP) | 3 weeks | ++ | - | +++ | ++ | ++ | +++ |
Matrix metalloproteinase-1 (MMP-1) | 3 weeks | ++ | + | - | - | + | - |
Matrix metalloproteinase-13 (MMP-13) | 3 weeks | +++ | ++ | ++ | +++ | ++ | +++ |
Interleukin-6 (IL-6) | 3 weeks | - | - | - | - | - | - |
mIgG | 3 weeks | - | - | - | - | - | - |
Cathepsin-K (CAT-K) | 6 weeks | +++ | ++ | + | ++ | ++ | + |
Alkaline phosphatase (ALP) | 6 weeks | - | - | ++ | +++ | ++ | ++ |
Matrix metalloproteinase-1 (MMP-1) | 6 weeks | ++ | + | - | + | - | - |
Matrix metalloproteinase-13 (MMP-13) | 6 weeks | +++ | +++ | + | +++ | +++ | + |
Interleukin-6 (IL-6) | 6 weeks | - | - | - | - | - | - |
mIgG | 6 weeks | - | - | - | - | - | - |
Grading was performed for each group at 2 sites–middle of the defect and margin of the defect.
The grading was based on the following criteria
(-) no staining
(+) weak staining up to 50%
(++) moderate staining 50–80%
(+++) strong staining 80–100%.